692 results
Page 8 of 35
6-K
EX-99.1
wkjs91
4 Dec 13
Live Filing
12:00am
6-K
EX-99.1
wczl1tceq3 uaivr
4 Dec 13
Teva and Takeda Announce Development and Distribution Agreement for Glatiramer Acetate for Multiple Sclerosis Treatment in Japan
12:00am
6-K
6szq6keh
4 Dec 13
Live Filing
12:00am
6-K
EX-99.1
vvnic vykjp4zxuf
27 Nov 13
Teva Announces Additional Regulatory Exclusivity for Treanda® (Bendamustine Hci) for Injection
12:00am
6-K
EX-99.1
jgy6hnlzi
25 Nov 13
Teva and Mylan Settle Copaxone® Patent Litigation In France, the Uk and the Netherlands
12:00am
6-K
EX-99.1
k2htdocgvr7f02ano1ad
25 Nov 13
Live Filing
12:00am
6-K
gpvt1wphsj
19 Nov 13
Live Filing
12:00am
6-K
EX-99.1
lk5cj
19 Nov 13
Live Filing
12:00am
6-K
EX-99.1
wf9jupnp imr5vzmr
18 Nov 13
Teva Announces Updates to Oncology Biologic Portfolio
12:00am
6-K
EX-99.1
xkf8 seubkuk50
31 Oct 13
Teva Reports Third Quarter 2013 Results
12:00am
6-K
ii2o1melx99tvht
31 Oct 13
Current report (foreign)
12:00am
6-K
EX-99.1
2608snoy19j1n0r
30 Oct 13
Teva Announces Departure of President and Ceo
12:00am
6-K
EX-99.1
pw5i55f
10 Oct 13
Live Filing
12:00am
6-K
EX-99.1
h1oe7d2z
9 Oct 13
Teva R&D in Focus - Respiratory Webinar for the investment communityOctober 8th, 2013
12:00am
6-K
w5kl5i
9 Oct 13
Teva R&D in Focus - Respiratory Webinar for the investment communityOctober 8th, 2013
12:00am
6-K
EX-99.1
karg5i
4 Oct 13
Live Filing
12:00am
6-K
EX-99.1
yhkthm
3 Oct 13
Teva Announces Favorable Ruling on Copaxone Patent Litigation In the Netherlands
12:00am
6-K
EX-99.1
7drmiwz xq5m7plb6xk
3 Oct 13
Teva to Present Further Results of Twenty-year Open-label Extension Study of Glatiramer Acetate 20 MG Daily for Relapsing-remitting Multiple Sclerosis
12:00am
6-K
EX-99.1
gst xdn3g4b6argwl
1 Oct 13
Live Filing
12:00am
6-K
EX-99.1
gro7x
1 Oct 13
Teva Announces Launch of Generic Zemplar® In the United States
12:00am